Clostridium difficile: historia de una infección emergente y su manejo actual

Contenido principal del artículo

Daniela Paciel
Julio César Medina Presentado

Detalles del artículo

Cómo citar
Paciel, D., & Medina Presentado, J. C. (2015). Clostridium difficile: historia de una infección emergente y su manejo actual. Anales De La Facultad De Medicina, Universidad De La República, Uruguay, 2(1), 87-95. Recuperado a partir de https://anfamed.edu.uy/index.php/rev/article/view/144
Sección
Noticias y perspectivas
Biografía del autor/a

Daniela Paciel, Facultad de Medicina, Universidad de la República

BINAME-CENDIM, Facultad de Medicina, Universidad de la República

Citas


  1. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol. 2011 Apr;32(4):387-90. http://dx.doi.org/10.1086/659156

  2. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372(9):825-34. http://dx.doi.org/10.1056/NEJMoa1408913

  3. Balassiano IT, Yates EA, Domingues RM, Ferreira EO. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. J Med Microbiol. 2012 Feb;61(Pt 2):169-79. http://dx.doi.org/10.1099/jmm.0.037077-0

  4. Asensio A, Monge D. Epidemiología de la infección por Clostridium difficile en España. Enferm Infecc Microbiol Clin. 2012;30(6):333–7. http://dx.doi.org/10.1016/j.eimc.2011.09.010

  5. Zumbado-Salas R, Gamboa-Coronado M-del-M, Rodríguez-Cavallini E, Chaves-Olarte E. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital. Am J Trop Med Hyg. 2008;79(2):164-5.

  6. Hernandez-Rocha C, Barra-Carrasco J, Pizarro-Guajardo M, Ibáñez P, Bueno SM, Sarker MR, et al. Epidemic Clostridium difficile ribotype 027 in Chile. Emerg Infect Dis. 2012;18(8):1370–2. http://dx.doi.org/10.3201/eid1808.120211

  7. Aguayo C, Flores R, Lévesque S, Araya P, Ulloa S, Lagos J, et al. Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. Epidemiol Infect. 2015 Feb 17;17:1-5. http://dx.doi.org/10.1017/S0950268815000023

  8. Lopardo G, Morfi-Otero R, Moran-Vázquez II, Noriega F, Zambrano B, Luxemburger C. Epidemiology of Clostridium difficile: a hospital-based descriptive study in Argentina and Mexico. Braz J Infect Dis. 2015;19(1):8–14. http://dx.doi.org/10.1016/j.bjid.2014.07.004

  9. Uruguay. Ministerio de Salud Pública. División Epidemiología. Infecciones por Clostridium difficile en hospitals centinela . Uruguay, 2012. [Internet] Montevideo: MSP; 2012 [citada 2015 mayo 29] Disponible en: http://www.msp.gub.uy/sites/default/files/Informe_ICD_2012.pdf.

  10. Grille P, Olano E, Bertullo H, Bagnulo H. Estudio sobre diarrea en una unidad de cuidados intensivos quirúrgica. Rev Med Urug 2006;22(2):136-42.

  11. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529–49. http://dx.doi.org/10.1128/CMR.00082-09

  12. Pituch H. Clostridium difficile is no longer just a nosocomial infection or an infection of adults. Int J Antimicrob Agents. 2009;33(Suppl. 1):S42–5. http://dx.doi.org/10.1016/S0924-8579(09)70016-0

  13. Hall IC, O’Toole E. Intestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficile. Am J Dis Child. 1935;49(2):390-402. http://dx.doi.org/10.1001/archpedi.1935.01970020105010

  14. Silva J Moacyr. Recent changes in Clostridium difficile infection. R. Einstein (San Pablo) [Internet]. 2012 [citado 2015 mayo 28];10(1):105-9. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082012000100023&lng=en http://dx.doi.org/10.1590/S1679-45082012000100023

  15. Blondeau JM. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea? J Antimicrob Chemother. 2009;63(2):238-42. http://dx.doi.org/10.1093/jac/dkn477

  16. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978;298(10):531-4.

  17. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55. http://dx.doi.org/10.1086/651706

  18. Debast SB, Bauer MP, Kuijper EJ; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20 (Suppl. 2):1–26. http://dx.doi.org/10.1111/1469-0691.12418

  19. Dubberke ER, Gerding DN, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;(Suppl 1):S81–S92. http://dx.doi.org/10.1086/591065

  20. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile- associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173(9):1037-42. http://dx.doi.org/10.1503/cmaj.050978

  21. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008;359(18):1932-40. http://dx.doi.org/10.1056/NEJMra0707500

  22. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ. 2004;171(1):51–8. http://dx.doi.org/10.1503/cmaj.1031189

  23. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O’Connor L, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013 Sept;369:1195-205. http://dx.doi.org/10.1056/NEJMoa1216064

  24. Bergogne-Berezin E. Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents. 2000;16(4):521-6. http://dx.doi.org/10.1016/S0924-8579(00)00293-4

  25. Gould CV, McDonald LC. Bench-to-bedside review: Clostridium difficile colitis. Crit Care. 2008;12(1):203. http://dx.doi.org/10.1186/cc6207

  26. Burkart NE, Kwaan MR, Shepela C, Madoff RD, Wang Y, Rothenberger DA, et al. Indications and relative utility of lower endoscopy in the management of Clostridium difficile infection. Gastroenterol Res Pract. 2011 Oct 17;2011:626582. http://dx.doi.org/10.1155/2011/626582

  27. Younus F, Steigbigel RT. Images in clinical medicine. Nodular Clostridium difficile colitis. N Engl J Med. 2004 Mar 4;350(10):e9. http://dx.doi.org/10.1056/ENEJMicm010423

  28. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45(3):302-7. http://dx.doi.org/10.1086/519265

  29. Nelson RL, Kelsey P, Leeman H, Meardon N, Patel H, Paul K, et al. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev. 2011 Sep 7;(9):CD004610. http://dx.doi.org/10.1002/14651858.CD004610.pub4

  30. Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012 Apr;12(4):281-9. http://dx.doi.org/10.1016/S1473-3099(11)70374-7

  31. Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013 May 31;31(5):CD006095. http://dx.doi.org/ 10.1002/14651858.CD006095.pub3

  32. Abougergi MS, Kwon JH. Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review. Dig Dis Sci. 2011;56(1):19-26. http://dx.doi.org/10.1007/s10620-010-1411-2

  33. Kapoor K, Chandra M, Nag D, Paliwal JK, Gupta RC, Saxena RC, et al. Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res. 1999;19:83–8.

  34. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53(10):994-1002. http://dx.doi.org/10.1093/cid/cir632

  35. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014 Nov 5;312(17):1772-8. http://dx.doi.org/10.1001/jama.2014.13875

  36. Ostrowsky B, Ruiz R, Brown S, Chung P, Koppelman E, van Deusen Lukas C, et al. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions. Infect Control Hosp Epidemiol. 2014 Oct;35(Suppl 3):S86-95. http://dx.doi.org/10.1086/677828